A recent study shows YiDiXie serum tests improve diagnostic accuracy for urothelial carcinoma and may complement imaging.
A recently approved antibody drug from Regeneron Pharmaceuticals eradicates residual traces of multiple myeloma after initial treatments, potentially allowing patients to avoid grueling bone marrow transplants, preliminary data from a small mid-stage trial suggest.
Discontinued drug for gastrointestinal discomfort
Topical ointment for rheumatic pain relief.
Discontinued acne treatment
Topical antibiotic for skin infections and burns
CNS stimulant for ADHD and narcolepsy
Discontinued topical analgesic
Past use in migraine prevention
Indications and availability
Historical use and regulatory status
People with dementia who received a shingles vaccine were significantly less likely to die from dementia than those who didn’t get the shot, according to findings of a large study, suggesting the vaccine could slow progression of the disease.
Stroke patients who can't get to the hospital quickly enough to be eligible for the usual clot-busting treatments may soon have another option, results from a mid-stage trial suggest.
Pfizer’s Tukysa added to maintenance therapy significantly delayed disease progression in patients with HER2-positive metastatic breast cancer who had responded well to initial treatment, according to results of a late-stage trial.
Applying an insecticide treatment used for soldiers’ uniforms to the cloths used to carry babies significantly reduced incidence of malaria in the children, researchers found.
An analysis of language used in grants awarded this year by the U.S. National Institutes of Health suggests that researchers are less likely now than previously to consider study participants' ethnic, racial and gender diversity – or less likely to admit in writing that they plan to do so.
